Construction of a Risk Prediction Model for Subsequent Bloodstream Infection in Intestinal Carriers of Carbapenem-Resistant Enterobacteriaceae: A Retrospective Study in Hematology Department and Intensive Care Unit

References

• Centers for Disease Control and Prevention, USA. Antibiotic resistance threats in the United States, 2019; 2019. Available from: https://www.cdc.gov/drugresistance/biggest-threats.html. Accessed 129, 2021.
   Google Scholar
• Peri AM, Potoski BA, Harris PNA, Paterson DL, Righi E. Antimicrobial treatment challenges in the era of carbapenem resistance. Diagn Microbiol Infect Dis. 2019;94:413–425. doi:10.1016/j.diagmicrobio.2019.01.02030905487
   PubMed Web of Science ®Google Scholar
• Bartsch SM, McKinnell JA, Mueller LE, et al. Potential economic burden of carbapenem-resistant Enterobacteriaceae (CRE) in the United States. Clin Microbiol Infect. 2017;23:48.e9–48.e16. doi:10.1016/j.cmi.2016.09.003
   Web of Science ®Google Scholar
• Jaiswal SR, Gupta S, Kumar RS, et al. Gut colonization with carbapenem-resistant Enterobacteriaceae adversely impacts the outcome in patients with hematological malignancies: results of a prospective surveillance study. Mediterr J Hematol Infect Dis. 2018;10:e2018025. doi:10.4084/mjhid.2018.02529755703
   PubMed Web of Science ®Google Scholar
• Sabino S, Soares S, Ramos F, Moretti M, Zavascki AP, Rigatto MH. A cohort study of the impact of carbapenem-resistant Enterobacteriaceae infections on mortality of patients presenting with sepsis. mSphere. 2019;4:e00052–19. doi:10.1128/mSphere.00052-1930971443
   PubMed Web of Science ®Google Scholar
• McConville TH, Sullivan SB, Gomez-Simmonds A, Whittier S, Uhlemann AC. Carbapenem-resistant Enterobacteriaceae colonization (CRE) and subsequent risk of infection and 90-day mortality in critically ill patients, an observational study. PLoS One. 2017;12:e0186195. doi:10.1371/journal.pone.018619529023567
   PubMed Web of Science ®Google Scholar
• Tischendorf J, de Avila RA, Safdar N. Risk of infection following colonization with carbapenem-resistant Enterobactericeae: a systematic review. Am J Infect Control. 2016;44:539–543. doi:10.1016/j.ajic.2015.12.00526899297
   PubMed Web of Science ®Google Scholar
• World Health Organization. Guidelines for the prevention and control of carbapenem-resistant Enterobacteriaceae, Acinetobacter baumannii and Pseudomonas aeruginosa in health care facilities; 2017. Available from: https://www.who.int/infection-prevention/publications/guidelines-cre/en/. Accessed 129, 2021.
   Google Scholar
• Magiorakos AP, Burns K, Rodríguez Baño J, et al. Infection prevention and control measures and tools for the prevention of entry of carbapenem-resistant Enterobacteriaceae into healthcare settings: guidance from the European Centre for Disease Prevention and Control. Antimicrob Resist Infect Control. 2017;6:113. doi:10.1186/s13756-017-0259-z29163939
   PubMed Web of Science ®Google Scholar
• Clinical and Laboratory Standards Institute, USA. Performance standards for antimicrobial susceptibility testing, M100 30th edition; 2020. Available from: https://clsi.org/standards/products/microbiology/documents/m100/. Accessed 129, 2021.
   Google Scholar
• Pouch SM, Satlin MJ. Carbapenem-resistant Enterobacteriaceae in special populations: solid organ transplant recipients, stem cell transplant recipients, and patients with hematologic malignancies. Virulence. 2017;8:391–402. doi:10.1080/21505594.2016.121347227470662
   PubMed Web of Science ®Google Scholar
• Kuiken NSS, Rings EHHM, Blijlevens NMA, Tissing WJE. Biomarkers and non-invasive tests for gastrointestinal mucositis. Support Care Cancer. 2017;25:2933–2941. doi:10.1007/s00520-017-3752-228536886
   PubMed Web of Science ®Google Scholar
• Frampton JE, Curran MP. Tigecycline. Drugs. 2005;65:2623–2637. doi:10.2165/00003495-200565180-0000816392879
   PubMed Web of Science ®Google Scholar
• Rodvold KA, Gotfried MH, Cwik M, Korth-Bradley JM, Dukart G, Ellis-Grosse EJ. Serum, tissue and body fluid concentrations of tigecycline after a single 100mg dose. J Antimicrob Chemother. 2006;58:1221–1229. doi:10.1093/jac/dkl40317012300
   PubMed Web of Science ®Google Scholar
• Sader HS, Flamm RK, Jones RN. Tigecycline activity tested against antimicrobial resistant surveillance subsets of clinical bacteria collected worldwide (2011). Diagn Microbiol Infect Dis. 2013;76:217–221. doi:10.1016/j.diagmicrobio.2013.02.00923522845
   PubMed Web of Science ®Google Scholar
• Decousser JW, Woerther PL, Soussy CJ, Fines-Guyon M, Dowzicky MJ. The tigecycline evaluation and surveillance trial; assessment of the activity of tigecycline and other selected antibiotics against gram-positive and gram-negative pathogens from France collected between 2004 and 2016. Antimicrob Resist Infect Control. 2018;7:68. doi:10.1186/s13756-018-0360-y29876099
   PubMed Web of Science ®Google Scholar
• Liu XJ, Lyu Y, Li Y, Xue F, Liu J. Trends in antimicrobial resistance against Enterobacteriaceae strains isolated from blood: a 10-year epidemiological study in mainland China (2004–2014). Chin Med J (Engl). 2017;130:2050–2055. doi:10.4103/0366-6999.21340728836547
   PubMed Web of Science ®Google Scholar
• Wang Q, Wang X, Wang J, et al. Phenotypic and genotypic characterization of carbapenem-resistant Enterobacteriaceae: data from a longitudinal large-scale CRE study in China (2012–2016). Clin Infect Dis. 2018;67(suppl_2):S196–S205. doi:10.1093/cid/ciy66030423057
   PubMed Web of Science ®Google Scholar
• Averbuch D, Tridello G, Hoek J, et al. Antimicrobial resistance in gram-negative rods causing bacteremia in hematopoietic stem cell transplant recipients: intercontinental prospective study of the infectious diseases working party of the European bone marrow transplantation group. Clin Infect Dis. 2017;65:1819–1828. doi:10.1093/cid/cix64629020364
   PubMed Web of Science ®Google Scholar
• Gu D, Dong N, Zheng Z, et al. A fatal outbreak of ST11 carbapenem-resistant hypervirulent Klebsiella pneumoniae in a Chinese hospital: a molecular epidemiological study. Lancet Infect Dis. 2018;18(1):37–46. doi:10.1016/S1473-3099(17)30489-928864030
   PubMed Web of Science ®Google Scholar
• Giannella M, Trecarichi EM, De Rosa FG, et al. Risk factors for carbapenem-resistant Klebsiella pneumoniae bloodstream infection among rectal carriers: a prospective observational multicentre study. Clin Microbiol Infect. 2014;20:1357–1362. doi:10.1111/1469-0691.1274724980276
   PubMed Web of Science ®Google Scholar